Thomas Phd Adams - Net Worth and Insider Trading
Thomas Phd Adams Net Worth
The estimated net worth of Thomas Phd Adams is at least $59,268 dollars as of 2024-11-13. Thomas Phd Adams is the Director of Cardiff Oncology Inc and owns about 18,875 shares of Cardiff Oncology Inc (CRDF) stock worth over $59,268. Details can be seen in Thomas Phd Adams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Phd Adams has not made any transactions after 2020-05-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Phd Adams
Thomas Phd Adams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Phd Adams owns 4 companies in total, including Hepion Pharmaceuticals Inc (HEPA) , Cardiff Oncology Inc (CRDF) , and Synergy Pharmaceuticals Inc (SGYPQ) among others .
Click here to see the complete history of Thomas Phd Adams’s form 4 insider trades.
Insider Ownership Summary of Thomas Phd Adams
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HEPA | Hepion Pharmaceuticals Inc | 2016-09-20 | director |
| CRDF | Cardiff Oncology Inc | 2020-05-14 | director |
| SGYPQ | Synergy Pharmaceuticals Inc | 2018-07-03 | director |
 | | 2003-09-18 | director |
Thomas Phd Adams Latest Holdings Summary
Thomas Phd Adams currently owns a total of 1 stock. Thomas Phd Adams owns 18,875 shares of Cardiff Oncology Inc (CRDF) as of May 14, 2020, with a value of $59,268.
Latest Holdings of Thomas Phd Adams
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2020-05-14 | 18,875 | 3.14 | 59,268 |
Holding Weightings of Thomas Phd Adams
Thomas Phd Adams Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Phd Adams has made a total of 1 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cardiff Oncology Inc is the acquisition of 13,986 shares on May 14, 2020, which cost Thomas Phd Adams around $20,000.
Insider Trading History of Thomas Phd Adams
- 1
Thomas Phd Adams Trading Performance
GuruFocus tracks the stock performance after each of Thomas Phd Adams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Phd Adams is 305.59%. GuruFocus also compares Thomas Phd Adams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Phd Adams within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas Phd Adams's insider trading performs compared to the benchmark.
Performance of Thomas Phd Adams
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 72.73 | | | | | |
| Relative Return to S&P 500(%) | 66.11 | | | | | |
Thomas Phd Adams Ownership Network
Ownership Network List of Thomas Phd Adams
Ownership Network Relation of Thomas Phd Adams
Thomas Phd Adams Owned Company Details
What does Hepion Pharmaceuticals Inc do?
Who are the key executives at Hepion Pharmaceuticals Inc?
Thomas Phd Adams is the director of Hepion Pharmaceuticals Inc. Other key executives at Hepion Pharmaceuticals Inc include Chief Scientific Officer Robert T Foster , Chief Financial Officer John T Cavan , and director & CEO and President Gary S Jacob .
Hepion Pharmaceuticals Inc (HEPA) Insider Trades Summary
Over the past 18 months, Thomas Phd Adams made no insider transaction in Hepion Pharmaceuticals Inc (HEPA). Other recent insider transactions involving Hepion Pharmaceuticals Inc (HEPA) include a net purchase of 8,000 shares made by Peter Wijngaard , and a net purchase of 3,200 shares made by Robert T Foster .
In summary, during the past 3 months, insiders sold 0 shares of Hepion Pharmaceuticals Inc (HEPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hepion Pharmaceuticals Inc (HEPA) were sold and 11,200 shares were bought by its insiders, resulting in a net purchase of 11,200 shares.
Hepion Pharmaceuticals Inc (HEPA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hepion Pharmaceuticals Inc Insider Transactions
Thomas Phd Adams Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Phd Adams. Currently GuruFocus does not have mailing address information for Thomas Phd Adams.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
